AbstractObjectives: AXL-mediated activation o…
AbstractPurpose: Agonists of the stimulator o…
Editorial: Development of small molecule inhibitor…
AbstractIntroduction: Osimertinib is a third-…
AbstractA recently developed treatment strategy fo…
AbstractAmong cancer cells, indoleamine 2, 3-dioxy…
AbstractThe development of cancer therapies using …
AbstractCancer cells are able to reprogram their g…
AbstractBackground: The predictive value of i…
AbstractObjective: Anti-programmed death (PD)…
AbstractUp to 40% of patients with epidermal growt…
AbstractEGFR exon 20 insertion driver mutatio…
AbstractBackground: EML4-ALK is a distin…
AbstractBackgroundWe investigated whether head and…
AbstractClinical benefit of ALK tyrosine…
